Treatment of benign prostatic hyperplasia and abnormal ejaculation: live imaging reveals tamsulosin – but not tadalafil – induced dysfunction of prostate, seminal vesicles and epididymis

In brief One of the most commonly prescribed benign prostatic hyperplasia (BPH) pharmacotherapies, the alpha1-adrenergic blocker tamsulosin, is frequently discontinued, especially by younger patients due to ejaculatory disorders, often without feedback to the attending physician. Using a newly devel...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Reproduction (Cambridge, England) England), 2022-12, Vol.164 (6), p.291-301
Hauptverfasser:	Seidensticker, Mathias, Tasch, Sabine, Mietens, Andrea, Exintaris, Betty, Middendorff, Ralf
Format:	Artikel
Sprache:	eng
Schlagworte:	Ejaculation Epididymis Humans Male Norepinephrine Prostate Prostatic Hyperplasia - chemically induced Prostatic Hyperplasia - drug therapy Seminal Vesicles Sulfonamides - adverse effects Tadalafil - pharmacology Tadalafil - therapeutic use Tamsulosin - pharmacology Tamsulosin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!